A detailed history of New Edge Advisors, LLC transactions in Zomedica Corp. stock. As of the latest transaction made, New Edge Advisors, LLC holds 60,700 shares of ZOM stock, worth $7,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,700
Previous 60,988 0.47%
Holding current value
$7,284
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.12 - $0.16 $34 - $46
-288 Reduced 0.47%
60,700 $8,000
Q2 2024

Aug 15, 2024

BUY
$0.12 - $0.18 $4,200 - $6,300
35,000 Added 134.68%
60,988 $9,000
Q4 2023

Feb 13, 2024

BUY
$0.15 - $0.22 $780 - $1,144
5,200 Added 25.01%
25,988 $5,000
Q3 2023

Nov 14, 2023

BUY
$0.16 - $0.23 $46 - $66
288 Added 1.4%
20,788 $3,000
Q4 2022

Feb 14, 2023

BUY
$0.16 - $0.25 $3,280 - $5,125
20,500 New
20,500 $3,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $118M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.